[Treatment of high grade intracranial stenoses]

P Dietrich1, C Roth, A Simgen

  • 1Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Kirrberger Straße, Homburg/Saar, Deutschland.

Der Radiologe
|November 27, 2012
PubMed

Insights

Intracranial stenosis causes 10% of strokes. This study retrospectively analyzed endovascular treatment for high-grade intracranial stenosis, comparing it with aggressive medical management.

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Medicine

Context:

  • Intracranial stenosis is a significant cause of stroke, accounting for approximately 10% of all cases.
  • Current treatment options include medical management, intracranial bypass surgery, and endovascular procedures like angioplasty and stenting.
  • Despite advances, patients with high-grade intracranial stenosis often face a poor prognosis, highlighting the need for effective therapies.

Purpose:

  • To retrospectively evaluate the effectiveness and feasibility of endovascular treatment (angioplasty and stenting) for symptomatic high-grade intracranial stenosis.
  • To compare the outcomes of endovascular therapy with aggressive medical treatment, as suggested by the SAMMPRIS trial.
  • To analyze patient data from the department of neuroradiology at Homburg University of Saarland.

Summary:

  • The study focuses on patients with symptomatic high-grade intracranial stenosis, a condition linked to a substantial stroke risk.
  • It examines intracranial angioplasty and stenting as endovascular treatment options, building upon previous research like the WASID trial.
  • Findings are contextualized within the broader debate on aggressive medical management versus endovascular intervention, particularly following the SAMMPRIS trial.

Impact:

  • Provides insights into the comparative effectiveness of endovascular treatment versus medical management for intracranial stenosis.
  • Contributes to the evidence base for managing patients with high-grade intracranial stenosis and reducing secondary stroke risk.
  • Informs clinical decision-making regarding treatment strategies for this challenging patient population.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...